Clinical Trial

A Mass Balance Study of [14C]ABSK011

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 26, 2025 (before its estimated November 7, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is a single-site, open-label, single-cohort, single-dose study to assess the absorption, metabolism, and excretion profile of \[14C\] ABSK011 in healthy adult male subjects. The study plans to enroll 6 to 8 healthy male subjects to ensure at least 6 evaluable subjects.
Trial Details
NCT Number NCT06896760
Lead Sponsor Abbisko Therapeutics Co, Ltd
Conditions Healthy Subjects
Enrollment 6 participants
Start Date 2025-04-07
Primary Completion 2025-11-07 (estimated)
Study Completion 2026-04-07 (estimated)
Updated on ClinicalTrials.gov 2025-03-26